Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.

Ongoing Phase 1b/2 Trial of the Allosteric MEK1/2 Inhibitor REC-4881 as Monotherapy (FAP): Updated Safety and Efficacy Najat Khan, Ph.D ., Chief R&D and Chief Commercial Officer and incoming CEO and ...

Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, announced today that it will present ...

Physics and Python stuff. Most of the videos here are either adapted from class lectures or solving physics problems. I really like to use numerical calculations without all the fancy programming ...

Abstract: We address the computational challenges of large-scale geospatial mapping with Gaussian process (GP) regression by performing localized computations rather than processing the entire map ...

Hi there, I'm using Unsloth's SFT library and it's been fairly buggy lately, and today it no longer functions. This code, from unsloth import FastLanguageModel import torch max_seq_length = 4096 # ...

Python 3.11 introduced the Specializing Adaptive Interpreter. When the interpreter detects that some operations predictably involve the same types, those operations are “specialized.” The generic ...